Immunomodulating effects in vitro of a hydroxythiazolobenzimidazole in the absence of mitogenicity.
Wy-13, 876, a hydroxythiazolobenzimidazole, enhanced in vitro antibody formation by mouse spleen cells immunized with sheep red blood cells. The optimal dose was 25--50 microgram/culture. The compound did not have a mitogenic effect at any dose.